Beyond gluten-free diet: Novel therapeutic frontiers in celiac disease armamentarium.

World J Gastrointest Pharmacol Ther · 2026 · PMC13248124 · PMID 42273246

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Though larazotide acetate could not demonstrate a statistically significant efficacy in the reduction of intestinal permeability, a favorable trend was seen[ 82 ].

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.